ResearcherThe First People's Hospital of NeijiangNo recent work listed
Tinggang Mou
Matched on ORCID iD 0009-0003-4082-141X; OpenAlex author ID A5040152778. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2018: 1 paper · 2019: 1 paper · 2020: 1 paper
Papers 3
- Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression. Co-author DOI 10.18632/aging.103487↗
- MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8. Co-author DOI 10.1016/j.biopha.2018.12.121↗
- Expression of miRNA-143 in Pancreatic Cancer and Its Clinical Significance. Co-author DOI 10.1089/cbr.2018.2500↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fei Xie · 3 shared papers, 2018–2020 · strength 0.31
- Paper Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343… DOI 10.18632/aging.103487↗
- Paper MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8. DOI 10.1016/j.biopha.2018.12.121↗
- Paper Expression of miRNA-143 in Pancreatic Cancer and Its Clinical Significance. DOI 10.1089/cbr.2018.2500↗
- Qin Yang · 2 shared papers, 2019–2020 · strength 0.23
- Hao Hua · 2 shared papers, 2019–2020 · strength 0.23
- Liang Lai · 2 shared papers, 2018–2019 · strength 0.19
- Jie Wang · 1 shared paper, 2020 · strength 0.12
- Xiao Chen · 1 shared paper, 2020 · strength 0.12
- Jie Wang · 1 shared paper, 2019 · strength 0.11
- Bo Xu · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.